European Journal of Medicinal Chemistry p. 197 - 209 (2018)
Update date:2022-08-05
Topics:
Guo, Jing
Zhao, Fan
Yin, Wenbo
Zhu, Mingyue
Hao, Chenzhou
Pang, Yu
Wu, Tianxiao
Wang, Jian
Zhao, Dongmei
Li, Haitao
Cheng, Maosheng
We have previously described the identification of indolin-2-one-5-carboxamides as potent PAK4 inhibitors. This study expands the structure-activity relationships on our original series by presenting several modifications in the lead compounds, 2 and 3. A series of novel derivatives was designed, synthesized, and evaluated in biochemical and cellular assay. Most of this series displayed nanomolar biochemical activity and potent antiproliferative activity against A549 and HCT116 cells. The representative compound 10a exhibited excellent enzyme inhibition (PAK4 IC50 = 25 nM) and cellular potency (A549 IC50 = 0.58 μM, HCT116 IC50 = 0.095 μM). An X-ray structure of compound 10a bound to PAK4 was obtained. Crystallographic analysis confirmed predictions from molecular modeling and helped refine SAR results. In addition, Compound 10a displayed focused multi-targeted kinase inhibition, good calculated drug-likeness properties. Further profiling of compound 10a revealed it showed weak inhibitory activity against various isoforms of human cytochrome P450.
View Morechengdu firsterchem Pharmaceutical Co., Ltd.
Contact:028-66825849
Address:chengdu
Contact:86-28-61993785
Address:No.70-13-21, North Section, Erhuan
ZHUHAI HAIRUIDE BIOSCIENCE AND TECHNOLOGY CO.,LTD
website:http://www.zhhairuide.com
Contact:+8613326687259/+86-756-7789199
Address:No.10 Yonghui Road
Contact:021
Address:Pudong
Zibo Jujin Chemical Industry Co., Ltd.(Dongming Jujin Chemical Industry Co., Ltd. )
Contact:+86-533-2975022
Address:No.99 Shanquan Road, Zhangdian District
Doi:10.1016/S0960-894X(01)00049-X
(2001)Doi:10.1248/cpb.48.843
(2000)Doi:10.1016/j.bmcl.2003.12.008
(2004)Doi:10.1139/v70-424
(1970)Doi:10.1016/S0040-4039(00)00488-3
(2000)Doi:10.1021/ja000743k
(2000)